# A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma

> **NCT00490451** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 101 (actual)

## Conditions studied

- Sarcoma, Soft Tissue

## Interventions

- **DRUG:** LY573636-sodium

## Key facts

- **NCT ID:** NCT00490451
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490451, "A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00490451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*